71.05
-2.05 (-2.81%)
| Previous Close | 73.10 |
| Open | 69.35 |
| Volume | 1,082,305 |
| Avg. Volume (3M) | 3,321,600 |
| Market Cap | 9,256,536,064 |
| Price / Earnings (Forward) | 1.25 |
| Price / Sales | 15.65 |
| Price / Book | 11.93 |
| 52 Weeks Range | |
| Earnings Date | 5 Nov 2026 |
| Profit Margin | -25.14% |
| Operating Margin (TTM) | -31.33% |
| Diluted EPS (TTM) | -1.30 |
| Quarterly Revenue Growth (YOY) | 9.80% |
| Total Debt/Equity (MRQ) | 11.33% |
| Current Ratio (MRQ) | 5.37 |
| Operating Cash Flow (TTM) | 56.74 M |
| Levered Free Cash Flow (TTM) | 95.16 M |
| Return on Assets (TTM) | -12.43% |
| Return on Equity (TTM) | -22.03% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (US) | Mixed | Bearish |
| Health Information Services (Global) | Mixed | Bearish | |
| Stock | 10x Genomics, Inc. | Mixed | Bullish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | -4.5 |
| Technical Moving Averages | 1.5 |
| Technical Oscillators | -0.5 |
| Relative Valuation | NA |
| Financial Health | NA |
| AI Insight | NA |
| Weighted Average | -1.17 |
Select this tab to load the latest available analysis.
|
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China). |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Small Core |
| % Held by Insiders | 1.93% |
| % Held by Institutions | 101.82% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |